The large majority of human genomes sequenced have been from humans of European descent. The limited research and genomic information available for patients of other ethnicities is alarming and detrimental. The many genomic projects like the HGP described above are not fulfilling their purpose in providing a comprehensive resource for analysis of common human genetic variation.
In a study cited below, the researchers discussed The 1000 Genome Project results as well as their implications. They particularly discussed the underrepresentation of certain populations including African Americans. This is especially alarming as the researchers explained how African ancestry populations have the greatest number of variant sites present in their genomes. There is also inadequate genomic understanding of the causes of many diseases in African Americans compared to the well-known genomic causes in cases of European descendants.
The sequencing and analyses of human genomes from humans of diverse ethnicities is an ethical necessity moving forward in the field of genomics. This will result in more effective diagnostics and treatments for more people than ever before. More diversity in human genomic databases would also be especially significant in treating rare diseases that often rely on genomic analyses for early detection and treatment.
Human genomics research has the potential to uncover physiological mechanisms of disease as sequenced genomes may indicate patients' physiological diseases as well as their causes and possible treatments. Gene editing through CRISPR is also a powerful and controversial tool that may play a role in treatments or even cures of physiological diseases in the near future.
Human genomics research has the potential to uncover physiological mechanisms of disease as sequenced genomes may indicate patients' physiological diseases as well as their causes and possible treatments. Gene editing through CRISPR is also a powerful and controversial tool that may play a role in treatments or even cures of physiological diseases in the near future.
Resources:
https://www.nature.com/articles/nature15393
https://blogs.scientificamerican.com/voices/we-need-more-diversity-in-our-genomic-databases/
https://www.nature.com/scitable/topicpage/dna-sequencing-technologies-key-to-the-human-828
http://pdflikeread.com/human-physiology-and-mechanisms-of-disease-arthur-c-guyton-first-online-free-books-arhive.pdf
http://pdflikeread.com/human-physiology-and-mechanisms-of-disease-arthur-c-guyton-first-online-free-books-arhive.pdf
Here are the citations in APA format:
ReplyDeleteChial, H. (n.d.). DNA Sequencing Technologies Key to the Human Genome Project. Retrieved from https://www.nature.com/scitable/topicpage/dna-sequencing-technologies-key-to-the-human-828
Consortium, T. 1. (2015, September 30). A global reference for human genetic variation. Retrieved from https://www.nature.com/articles/nature15393
Korlach, J. (2018, December 04). We Need More Diversity in Our Genomic Databases. Retrieved from https://blogs.scientificamerican.com/voices/we-need-more-diversity-in-our-genomic-databases/
Good job giving a brief overview on The Human Genome Project and I am glad you mentioned the lack of diversity! There are so many ethical concerns with CRISPR, though the possibility of its use in the future is definitely exciting to think about. In the future I hope that gene sequencing will become a more common practice to personalize the types of treatment and therapies used for those with rarer diseases. As of now, gene sequencing can be very expensive, so it's limited to those who can afford to pay it. This is an unfortunate reality as we know that disease does not discriminate between the rich and poor.
ReplyDelete